These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Acidic glycosaminoglycans and gangliosides in the brains from four patients with genetic mucopolysaccharidosis. Ikeno T; Minami R; Tsugawa S; Nakao T Tohoku J Exp Med; 1982 Jul; 137(3):253-60. PubMed ID: 6810503 [TBL] [Abstract][Full Text] [Related]
24. Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome. Martell LA; Cunico RL; Ohh J; Fulkerson W; Furneaux R; Foehr ED Bioanalysis; 2011 Aug; 3(16):1855-66. PubMed ID: 21877895 [TBL] [Abstract][Full Text] [Related]
25. The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Harmatz P; Mengel KE; Giugliani R; Valayannopoulos V; Lin SP; Parini R; Guffon N; Burton BK; Hendriksz CJ; Mitchell J; Martins A; Jones S; Guelbert N; Vellodi A; Hollak C; Slasor P; Decker C Mol Genet Metab; 2013 May; 109(1):54-61. PubMed ID: 23452954 [TBL] [Abstract][Full Text] [Related]
40. Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y. Jones SA; Bialer M; Parini R; Martin K; Wang H; Yang K; Shaywitz AJ; Harmatz P Pediatr Res; 2015 Dec; 78(6):717-22. PubMed ID: 26331768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]